PROTEKTProspective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin
References in periodicals archive ?
pneumoniae isolates collected at 119 centers in year 6 of PROTEKT US, 2,381 (35.
A key finding in PROTEKT was that telithromycin was highly active against S.
Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
A number of industry-sponsored global surveillance studies, such as the Alexander Project (GlaxoSmithKline) and PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) (sanofi-aventis), have been designed to define and monitor the prevalence and distribution of antimicrobial resistance among respiratory pathogens, detect new patterns of resistance, provide early warning of emerging resistance, and evaluate the effects of interventions aimed at reducing antimicrobial resistance.
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000 2001 PROTEKT US Study.
Streptococcus pneumoniae isolates (N = 31,001) were collected from patients with community-acquired respiratory tract infections during the PROTEKT US surveillance study (2000-2003).
Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
pneumoniae have been identified (84) in over 10,000 pneumococcal isolates screened by the PROTEKT study (10).